Featured Research

from universities, journals, and other organizations

Infants With Bronchiolitis May Benefit More From Albuterol

Date:
May 17, 2007
Source:
Elsevier Health Sciences
Summary:
Bronchiolitis, a wheezing much like asthma in adults, is responsible for many hospital admissions of infants. There are two drugs in general use to treat this condition, epinephrine and albuterol, and there is some controversy and passion involved in the choice of medication. In a new article a double-blind randomized clinical trial involving over 700 infants showed a clear advantage for albuterol.

Bronchiolitis, a wheezing much like asthma in adults, is responsible for many hospital admissions of infants. It is the commonest cause of hospital admission in this age group. There are two drugs in general use to treat this condition, epinephrine and albuterol, and there is some controversy and passion involved in the choice of medication.

In a paper to be presented at the 2007 Society for Academic Emergency Medicine (SAEM) Annual Meeting, a double-blind randomized clinical trial involving over 700 infants over a three year period showed a clear advantage for albuterol in successful discharges from the Emergency Department.

Although many smaller studies have shown either no difference or an advantage to epinephrine, this surprising result of a small but real advantage in using albuterol may force physicians to reassess their treatment choices. Principal Investigaor, Paul Walsh, MD, originally preferred epinephrine prior to conducting this study. The other investigators were Kemedy McQuillan MD, John Caldwel Pharm Dl and Stephen J Rothenberg PhD.

The presentation is entitled "A Double Blind Randomized Controlled Trial Comparing Nebulized Epinephrine And Albuterol In The Emergency Department Treatment Of Bronchiolitis" by Paul Walsh MD, of the Kern Medical Center, Bakersfield & David Geffen School of Medicine at the UCLA, Los Angeles, CA. This paper will be presented at the 2007 SAEM Annual Meeting, May 16-19, 2007, Chicago, IL. Abstracts of the papers presented are published in Volume 14, Issue 5S, the May 2007 supplement of the official journal of the SAEM, Academic Emergency Medicine.


Story Source:

The above story is based on materials provided by Elsevier Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

Elsevier Health Sciences. "Infants With Bronchiolitis May Benefit More From Albuterol." ScienceDaily. ScienceDaily, 17 May 2007. <www.sciencedaily.com/releases/2007/05/070516071538.htm>.
Elsevier Health Sciences. (2007, May 17). Infants With Bronchiolitis May Benefit More From Albuterol. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2007/05/070516071538.htm
Elsevier Health Sciences. "Infants With Bronchiolitis May Benefit More From Albuterol." ScienceDaily. www.sciencedaily.com/releases/2007/05/070516071538.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins